Will Merck (US) Q2 2011 Most Resemble Geman Merck On Friday? Look Like Lilly? Or Like Novartis?

So, come Friday at 8 am EDT, will the New Merck post a German Merck-Serono style disappointment, an Eli Lilly-stlye yawner, or a Novartis-style winner/suprisingly strong Q2 2011?

We’ll see — and live blog it here — and you may listen in, right here:

. . . .Merck will hold its second-quarter 2011 sales and earnings conference call with institutional investors and analysts at 8 a.m. EDT on Friday, July 29. During the call, Kenneth C. Frazier, president and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Adam H. Schechter, president, Global Human Health, will provide an overview of Merck’s financial performance for the quarter. . . .

WHAT’S EXPECTED: Analysts surveyed by FactSet forecast earnings per share of 95 cents and sales of $11.81 billion. . . .

See you Friday.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s